Increasing bacterial burden in the lower airways of patients with idiopathic pulmonary
fibrosis confers an increased risk of disease progression and mortality. However, it remains …

Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive lung disease. Despite years
of investigation, the cause of IPF remains enigmatic. The disease is likely multifactorial, with …

Rationale: Changes in the respiratory microbiome are associated with disease progression
in idiopathic pulmonary fibrosis (IPF). The role of the host response to the respiratory …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown
cause that leads to respiratory failure and death within 5 years of diagnosis. Overt …

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) have been defined as events
of clinically significant respiratory deterioration with an unidentifiable cause. They carry a …

1 Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic
classification. Am J Respir Crit Care Med 1998; 157: 1301–1315 2 Travis WD, Matsui K …

Numerous studies have been published investigating the pathologic alterations in various
interstitial pneumonias, particularly in idiopathic pulmonary fibrosis (IPF). However, the few …

Background Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe form of
idiopathic interstitial pneumonias. Although IPF has not been thought to be associated with …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease that commonly affects older adults and is associated with the histopathological …

Aims: To identify individual histopathological features within usual interstitial pneumonia
pattern that predict responsiveness to immunosuppressive therapy. Methods and results …